U.S. court permitting Dr. Reddy’s to sell a generic version of British drugmaker Indivior’s opioid dependence treatment drug Suboxone. The United States Court of Appeals for the Federal Circuit issued a decision in favour of Dr. Reddy’s Laboratories Inc . As a result of the ruling, Dr. Reddy’s said it will resume the launch activities, for the generic drug, as soon as permitted. The US Food and Drug Administration (USFDA) approved Dr.Reddy’s Buprenorphine and Naloxone Sublingual Film for sale in the U.S. market.
Tags : #US Court#Permission Granted#Generic Drug